JEAN JACQUES BIENAIME Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEAN JACQUES BIENAIME.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEAN JACQUES BIENAIME. JEAN JACQUES BIENAIME is Director in INCYTE CORP ($INCY) and Chief Executive Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in VITAL THERAPIES INC ($VTL).
Latest Insider Trading Transactions of JEAN JACQUES BIENAIME
Sentiment: All, BMRN, VTL, INCY
Page: < prev 1 2 3 4 5 5 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 1,000 | 21,510 | 138,000 | |
| Sep 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 1,000 | 21,510 | 138,000 | |
| Sep 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 1,000 | 21,510 | 327,520 | 326.5 K to 327.5 K (+0.31 %) |
| Sep 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 1,000 | 21,510 | 327,520 | 326.5 K to 327.5 K (+0.31 %) |
| Aug 05 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Sell | S | 84.73 | 377 | 31,943 | 7,055 | 7.4 K to 7.1 K (-5.07 %) |
| Aug 05 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Sell | S | 85.16 | 1,347 | 114,711 | 7,432 | 8.8 K to 7.4 K (-15.34 %) |
| May 14 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 10,000 | 143,900 | 0 | |
| May 14 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.52 | 10,000 | 825,193 | 326,520 | 336.5 K to 326.5 K (-2.97 %) |
| May 14 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 10,000 | 143,900 | 336,520 | 326.5 K to 336.5 K (+3.06 %) |
| May 13 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 10,000 | |
| May 13 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 81.97 | 4,000 | 327,888 | 326,520 | 330.5 K to 326.5 K (-1.21 %) |
| May 13 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 330,520 | 326.5 K to 330.5 K (+1.23 %) |
| May 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 14,000 | |
| May 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.16 | 4,000 | 328,625 | 326,520 | 330.5 K to 326.5 K (-1.21 %) |
| May 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 330,520 | 326.5 K to 330.5 K (+1.23 %) |
| May 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 68.78 | 309 | 21,254 | 326,520 | 326.2 K to 326.5 K (+0.09 %) |
| Apr 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 3,000 | 43,170 | 18,000 | |
| Apr 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.41 | 200 | 16,881 | 326,211 | 326.4 K to 326.2 K (-0.06 %) |
| Apr 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 83.59 | 800 | 66,870 | 326,411 | 327.2 K to 326.4 K (-0.24 %) |
| Apr 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.44 | 2,000 | 164,889 | 327,211 | 329.2 K to 327.2 K (-0.61 %) |
| Apr 30 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 3,000 | 43,170 | 329,211 | 326.2 K to 329.2 K (+0.92 %) |
| Apr 29 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 75.03 | 12,472 | 935,774 | 12,472 | |
| Apr 29 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 0.00 | 1,520 | 0 | 8,584 | 7.1 K to 8.6 K (+21.52 %) |
| Apr 18 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 1,000 | 21,510 | 139,000 | |
| Apr 18 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 1,000 | 21,510 | 326,211 | 325.2 K to 326.2 K (+0.31 %) |
| Apr 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 21,000 | |
| Apr 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 25,000 | |
| Apr 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.12 | 4,000 | 356,480 | 325,211 | 329.2 K to 325.2 K (-1.22 %) |
| Apr 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 329,211 | 325.2 K to 329.2 K (+1.23 %) |
| Apr 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 325,211 | 324.2 K to 325.2 K (+0.31 %) |
| Apr 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 3,000 | 43,170 | 29,000 | |
| Apr 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 93.67 | 700 | 65,572 | 324,211 | 324.9 K to 324.2 K (-0.22 %) |
| Apr 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 92.39 | 100 | 9,239 | 324,911 | 325 K to 324.9 K (-0.03 %) |
| Apr 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.27 | 2,200 | 200,787 | 325,011 | 327.2 K to 325 K (-0.67 %) |
| Apr 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 3,000 | 43,170 | 327,211 | 324.2 K to 327.2 K (+0.93 %) |
| Apr 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 3,000 | 43,170 | 29,000 | |
| Apr 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 93.37 | 3,000 | 280,114 | 324,211 | 327.2 K to 324.2 K (-0.92 %) |
| Apr 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 3,000 | 43,170 | 327,211 | 324.2 K to 327.2 K (+0.93 %) |
| Apr 02 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 86.01 | 168 | 14,450 | 7,064 | 6.9 K to 7.1 K (+2.44 %) |
| Mar 29 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 32,000 | |
| Mar 29 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 324,211 | 323.2 K to 324.2 K (+0.31 %) |
| Mar 26 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 33,000 | |
| Mar 26 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 87.86 | 4,000 | 351,440 | 323,211 | 327.2 K to 323.2 K (-1.22 %) |
| Mar 26 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 327,211 | 323.2 K to 327.2 K (+1.24 %) |
| Mar 26 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 88.05 | 13,127 | 1,155,832 | 323,211 | 336.3 K to 323.2 K (-3.90 %) |
| Mar 21 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 37,000 | |
| Mar 21 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 336,338 | 335.3 K to 336.3 K (+0.30 %) |
| Mar 19 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 38,000 | |
| Mar 19 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 94.53 | 87,080 | 8,231,672 | 87,080 | |
| Mar 19 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 94.40 | 4,000 | 377,600 | 335,338 | 339.3 K to 335.3 K (-1.18 %) |
| Mar 19 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 339,338 | 335.3 K to 339.3 K (+1.19 %) |
| Mar 19 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 34,780 | 0 | 335,338 | 300.6 K to 335.3 K (+11.57 %) |
| Mar 19 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 94.53 | 28,143 | 2,660,358 | 300,558 | 328.7 K to 300.6 K (-8.56 %) |
| Mar 14 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 3,000 | 43,170 | 42,000 | |
| Mar 14 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 93.42 | 3,000 | 280,253 | 328,701 | 331.7 K to 328.7 K (-0.90 %) |
| Mar 14 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 3,000 | 43,170 | 331,701 | 328.7 K to 331.7 K (+0.91 %) |
| Mar 13 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 45,000 | |
| Mar 13 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 5,000 | 71,950 | 49,000 | |
| Mar 13 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.44 | 4,000 | 365,770 | 328,701 | 332.7 K to 328.7 K (-1.20 %) |
| Mar 13 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 332,701 | 328.7 K to 332.7 K (+1.22 %) |
| Mar 13 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.96 | 5,000 | 444,780 | 328,701 | 333.7 K to 328.7 K (-1.50 %) |
| Mar 13 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 5,000 | 71,950 | 333,701 | 328.7 K to 333.7 K (+1.52 %) |
| Mar 08 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 54,000 | |
| Mar 08 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 54,000 | |
| Mar 08 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 90.78 | 4,000 | 363,120 | 328,701 | 332.7 K to 328.7 K (-1.20 %) |
| Mar 08 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 90.78 | 4,000 | 363,120 | 328,701 | 332.7 K to 328.7 K (-1.20 %) |
| Mar 08 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 332,701 | 328.7 K to 332.7 K (+1.22 %) |
| Mar 08 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 332,701 | 328.7 K to 332.7 K (+1.22 %) |
| Mar 05 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 94.76 | 4,909 | 465,177 | 328,701 | 333.6 K to 328.7 K (-1.47 %) |
| Mar 05 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 45,320 | 0 | 333,610 | 288.3 K to 333.6 K (+15.72 %) |
| Feb 28 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 58,000 | |
| Feb 28 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.78 | 4,000 | 367,120 | 288,290 | 292.3 K to 288.3 K (-1.37 %) |
| Feb 28 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 292,290 | 288.3 K to 292.3 K (+1.39 %) |
| Feb 22 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 3,000 | 43,170 | 62,000 | |
| Feb 22 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 90.12 | 3,000 | 270,360 | 288,290 | 291.3 K to 288.3 K (-1.03 %) |
| Feb 22 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 3,000 | 43,170 | 291,290 | 288.3 K to 291.3 K (+1.04 %) |
| Feb 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 65,000 | |
| Feb 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 95.20 | 4,000 | 380,800 | 288,290 | 292.3 K to 288.3 K (-1.37 %) |
| Feb 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 292,290 | 288.3 K to 292.3 K (+1.39 %) |
| Feb 07 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 69,000 | |
| Feb 07 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 98.63 | 4,000 | 394,520 | 288,290 | 292.3 K to 288.3 K (-1.37 %) |
| Feb 07 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 292,290 | 288.3 K to 292.3 K (+1.39 %) |
| Jan 24 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 3,000 | 43,170 | 73,000 | |
| Jan 24 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 96.82 | 3,000 | 290,460 | 288,290 | 291.3 K to 288.3 K (-1.03 %) |
| Jan 24 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 3,000 | 43,170 | 291,290 | 288.3 K to 291.3 K (+1.04 %) |
| Jan 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 76,000 | |
| Jan 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 93.79 | 4,000 | 375,160 | 288,290 | 292.3 K to 288.3 K (-1.37 %) |
| Jan 15 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 292,290 | 288.3 K to 292.3 K (+1.39 %) |
| Jan 11 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 3,000 | 43,170 | 80,000 | |
| Jan 11 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 90.55 | 3,000 | 271,650 | 288,290 | 291.3 K to 288.3 K (-1.03 %) |
| Jan 11 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 3,000 | 43,170 | 291,290 | 288.3 K to 291.3 K (+1.04 %) |
| Jan 10 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 6,000 | 86,340 | 83,000 | |
| Jan 10 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.73 | 3,401 | 311,990 | 288,290 | 291.7 K to 288.3 K (-1.17 %) |
| Jan 10 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.55 | 1,599 | 146,388 | 291,691 | 293.3 K to 291.7 K (-0.55 %) |
| Jan 10 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.14 | 1,000 | 91,144 | 293,290 | 294.3 K to 293.3 K (-0.34 %) |
| Jan 10 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 6,000 | 86,340 | 294,290 | 288.3 K to 294.3 K (+2.08 %) |
| Jan 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 3,000 | 43,170 | 89,000 | |
| Jan 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 87.58 | 3,000 | 262,740 | 288,290 | 291.3 K to 288.3 K (-1.03 %) |
| Jan 09 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 3,000 | 43,170 | 291,290 | 288.3 K to 291.3 K (+1.04 %) |
| Jan 03 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 63.59 | 228 | 14,499 | 6,896 | 6.7 K to 6.9 K (+3.42 %) |
| Jan 02 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 3,000 | 43,170 | 92,000 | |
| Jan 02 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.04 | 3,000 | 252,120 | 288,290 | 291.3 K to 288.3 K (-1.03 %) |
| Jan 02 2019 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 3,000 | 43,170 | 291,290 | 288.3 K to 291.3 K (+1.04 %) |
| Dec 27 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 95,000 | |
| Dec 27 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.50 | 4,000 | 322,000 | 288,290 | 292.3 K to 288.3 K (-1.37 %) |
| Dec 27 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 292,290 | 288.3 K to 292.3 K (+1.39 %) |
| Dec 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 2,000 | 35,720 | 0 | |
| Dec 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 92.64 | 2,000 | 185,280 | 288,290 | 290.3 K to 288.3 K (-0.69 %) |
| Dec 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 2,000 | 35,720 | 290,290 | 288.3 K to 290.3 K (+0.69 %) |
| Dec 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Gift | G | 0.00 | 540 | 0 | 181,501 | 182 K to 181.5 K (-0.30 %) |
| Dec 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Gift | G | 0.00 | 160 | 0 | 182,041 | 182.2 K to 182 K (-0.09 %) |
| Dec 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 2,000 | 35,720 | 2,000 | |
| Dec 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 93.12 | 2,000 | 186,240 | 288,290 | 290.3 K to 288.3 K (-0.69 %) |
| Dec 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 2,000 | 35,720 | 290,290 | 288.3 K to 290.3 K (+0.69 %) |
| Nov 09 2018 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Buy | P | 68.91 | 500 | 34,455 | 6,668 | 6.2 K to 6.7 K (+8.11 %) |
| Nov 09 2018 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Buy | P | 68.62 | 500 | 34,310 | 6,168 | 5.7 K to 6.2 K (+8.82 %) |
| Nov 05 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 1,500 | 26,790 | 4,000 | |
| Nov 05 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 97.88 | 1,500 | 146,820 | 288,290 | 289.8 K to 288.3 K (-0.52 %) |
| Nov 05 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 1,500 | 26,790 | 289,790 | 288.3 K to 289.8 K (+0.52 %) |
| Nov 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 4,000 | 57,560 | 99,000 | |
| Nov 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 92.55 | 4,000 | 370,200 | 288,290 | 292.3 K to 288.3 K (-1.37 %) |
| Nov 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 4,000 | 57,560 | 292,290 | 288.3 K to 292.3 K (+1.39 %) |
| Nov 01 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 103,000 | |
| Nov 01 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 288,290 | 287.3 K to 288.3 K (+0.35 %) |
| Oct 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 104,000 | |
| Oct 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 287,290 | 286.3 K to 287.3 K (+0.35 %) |
| Oct 05 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 1,500 | 26,790 | 5,500 | |
| Oct 05 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 99.36 | 1,500 | 149,040 | 286,290 | 287.8 K to 286.3 K (-0.52 %) |
| Oct 05 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 1,500 | 26,790 | 287,790 | 286.3 K to 287.8 K (+0.52 %) |
| Oct 02 2018 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 69.08 | 209 | 14,438 | 5,668 | 5.5 K to 5.7 K (+3.83 %) |
| Sep 27 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 105,000 | |
| Sep 27 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 286,290 | 285.3 K to 286.3 K (+0.35 %) |
| Sep 24 2018 | VTL | VITAL THERAPIES IN ... | BIENAIME JEAN JACQUES | Director | Sell | S | 0.30 | 26,619 | 8,002 | 18,500 | 45.1 K to 18.5 K (-59.00 %) |
| Sep 17 2018 | VTL | VITAL THERAPIES IN ... | BIENAIME JEAN JACQUES | Director | Sell | S | 0.47 | 20,000 | 9,400 | 45,119 | 65.1 K to 45.1 K (-30.71 %) |
| Sep 17 2018 | VTL | VITAL THERAPIES IN ... | BIENAIME JEAN JACQUES | Director | Sell | S | 0.47 | 20,000 | 9,400 | 45,119 | 65.1 K to 45.1 K (-30.71 %) |
| Sep 06 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 1,500 | 26,790 | 7,000 | |
| Sep 06 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 98.16 | 1,500 | 147,240 | 285,290 | 286.8 K to 285.3 K (-0.52 %) |
| Sep 06 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 1,500 | 26,790 | 286,790 | 285.3 K to 286.8 K (+0.53 %) |
| Jul 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 1,500 | 26,790 | 8,500 | |
| Jul 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 101.69 | 1,500 | 152,535 | 285,290 | 286.8 K to 285.3 K (-0.52 %) |
| Jul 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 1,500 | 26,790 | 286,790 | 285.3 K to 286.8 K (+0.53 %) |
| Jul 03 2018 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Grant | A | 67.00 | 216 | 14,472 | 5,459 | 5.2 K to 5.5 K (+4.12 %) |
| Jun 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 106,000 | |
| Jun 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 285,290 | 284.3 K to 285.3 K (+0.35 %) |
| Jun 06 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 92.07 | 6,310 | 580,962 | 284,290 | 290.6 K to 284.3 K (-2.17 %) |
| May 25 2018 | VTL | VITAL THERAPIES IN ... | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 6.10 | 29,538 | 180,182 | 29,538 | |
| May 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 0 | |
| May 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.66 | 18,750 | 1,662,356 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 17 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 18,750 |